Dextech Medical AB (XSAT:DEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
9.98
+0.28 (2.89%)
At close: Sep 14, 2026

Dextech Medical AB Balance Sheet

Millions SEK. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
8.6314.7119.0425.2435.47
Cash & Short-Term Investments
8.6314.7119.0425.2435.47
Cash Growth
-41.32%-22.76%-24.54%-28.86%926.20%
Accounts Receivable
0.49----
Other Receivables
-0.090.130.110.2
Receivables
0.490.090.130.110.2
Other Current Assets
-0.380.50.470.35
Total Current Assets
9.1215.1819.6825.8236.02
Long-Term Investments
00000
Other Intangible Assets
9.840.250.250.250.39
Long-Term Deferred Charges
-9.6710.668.973.18
Total Assets
18.9525.130.5935.0339.59

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
-0.130.280.150.25
Accrued Expenses
-0.180.690.550.43
Other Current Liabilities
0.650.020.010.020.03
Total Current Liabilities
0.650.340.980.720.71
Total Liabilities
0.650.340.980.720.71

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
18.30.830.830.830.83
Additional Paid-In Capital
-105.2105.2105.2105.2
Retained Earnings
--81.26-76.42-71.71-67.15
Shareholders' Equity
18.324.7629.6134.3138.88
Total Liabilities & Equity
18.9525.130.5935.0339.59

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
8.6314.7119.0425.2435.47
Net Cash Growth
-41.32%-22.76%-24.54%-28.86%926.20%
Net Cash Per Share
0.470.791.011.372.09
Filing Date Shares Outstanding
18.4918.4918.4918.4918.49
Total Common Shares Outstanding
18.4918.4918.4918.4918.49
Working Capital
8.4714.8518.725.135.31
Book Value Per Share
0.991.341.601.862.10
Tangible Book Value
8.4724.5129.3634.0738.49
Tangible Book Value Per Share
0.461.331.591.842.08